Recent data indicate that sputum expression of ACE2 mRNA is reduced in subjects with asthma who are taking ICSs,17 but whether similar suppression occurs in the context of COPD is unclear. This evidence concerns the gene ACE2 and chronic obstructive pulmonary disease.